Treatment of mast cells with carbon dioxide suppresses degranulation via a novel mechanism involving repression of increased intracellular calcium levels

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 66, Issue 3, 2011, Pages 341-350

  Strider, J W ^a   Masterson, C G ^a   Durham, P L ^a  

^a MISSOURI STATE UNIVERSITY   (United States)

Author keywords

48 80; allergic rhinitis; calcium; carbon dioxide; histamine; mast cells

Indexed keywords

CALCIUM; CARBON DIOXIDE; HISTAMINE; SULFORHODAMINE B;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; HAY FEVER; HISTAMINE RELEASE; MALE; MAST CELL DEGRANULATION; NONHUMAN; PERITONEUM MAST CELL; PRIORITY JOURNAL; RAT;

ANIMALS; CALCIUM; CARBON DIOXIDE; CELL DEGRANULATION; CELLS, CULTURED; FORMALDEHYDE; HISTAMINE RELEASE; IMMUNOSUPPRESSIVE AGENTS; INTRACELLULAR SPACE; MALE; MAST CELLS; P-METHOXY-N-METHYLPHENETHYLAMINE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 79551656409     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2010.02482.x     Document Type: Article

References (41)

1. Church MK, Levi-Schaffer F,. The human mast cell. J Allergy Clin Immunol 1997; 99: 155-160.
2. Pawankar R,. Mast cells in allergic airway disease and chronic rhinosinusitis. Chem Immunol Allergy 2005; 87: 111-129.
3. Levy D, Burstein R, Kainz V, Jakubowski M, Strassman AM,. Mast cell degranulation activates a pain pathway underlying migraine headache. Pain 2007; 130: 166-176.
4. Wallace DV, Dykewicz MS, Bernstein DI, Blessing-Moore J, Cox L, Khan DA, et al. The diagnosis and management of rhinitis: an updated practice parameter. J Allergy Clin Immunol 2008; 2 (Suppl): S1-S84. (Pubitemid 352033573)
5. Nathan RA,. The burden of allergic rhinitis. Allergy Asthma Proc 2007; 28: 3-9.
6. Nathan RA,. Management of patients with allergic rhinitis and asthma: literature review. South Med J 2009; 102: 935-941.
7. Casale T, Romero F, Spierings E,. Intranasal noninhaled carbon dioxide for the symptomatic treatment of seasonal allergic rhinitis. J Allergy Clin Immunol 2008; 121: 105-109.
8. Wang DY, Clement P,. Pathogenic mechanisms underlying the clinical symptoms of allergic rhinitis. Am J Rhinol 2000; 14: 325-333.
9. Baraniuk JN,. Mechanisms of allergic rhinitis. Curr Allergy Asthma Rep 2001; 1: 207-217.
10. Poole JA, Rosenwasser LJ,. The role of immunoglobulin E and immune inflammation: implications in allergic rhinitis. Curr Allergy Asthma Rep 2005; 5: 252-258.
11. Ishizaka T, Ishizaka K,. Activation of mast cells for mediator release through IgE receptors. Prog Allergy 1984; 34: 188-235.
12. Zhang J, Berenstein E, Siraganian RP,. Phosphorylation of Tyr342 in the linker region of Syk is critical for Fc epsilon RI signaling in mast cells. Mol Cell Biol 2002; 22: 8144-8154.
13. Eiseman E, Bolen JB,. Engagement of the high-affinity IgE receptor activates src protein-related tyrosine kinases. Nature 1992; 355: 78-80.
14. Hata D, Kawakami Y, Inagaki N, Lantz CS, Kitamura T, Khan WN, et al. Involvement of Brutons tyrosine kinase in FcepsilonRI-dependent mast cell degranulation and cytokine production. J Exp Med 1998; 187: 1235-1247.
15. Akdis CA, Blaser K,. Histamine in the immune regulation of allergic inflammation. J Allergy Clin Immunol 2003; 112: 15-22.
16. Fawcett DW,. Cytological and pharmacological observations on the release of histamine by mast cells. J Exp Med 1954; 100: 217-224.
17. Baraniuk J, Kaliner M,. Neuropeptides and nasal secretion. Am J Physiol 1991; 261: L223-L235.
18. Kulka M, Sheen CH, Tancowny BP, Grammer LC, Schleimer RP,. Neuropeptides activate human mast cell degranulation and chemokine production. Immunology 2008; 123: 398-410.
19. Cross LJ, Heaney LG, Ennis M,. Histamine release from human bronchoalveolar lavage mast cells by neurokinin A and bradykinin. Inflamm Res 1997; 46: 306-309.
20. Ogawa K, Nabe T, Yamamura H, Kohno S,. Nanomolar concentrations of neuropeptides induce histamine release from peritoneal mast cells of a substrain of Wistar rats. Eur J Pharmacol 1999; 374: 285-291.
21. Habara Y, Kanno T,. Perimetric [Ca2+]i rise and exocytosis detected by ultraviolet laser scanning confocal microscopy in rat peritoneal mast cells. Exp Physiol 1996; 81: 319-328.
22. Janiszewski J, Huizinga JD, Blennerhassett MG,. Mast cell ionic channels: significance for stimulus-secretion coupling. Can J Physiol Pharmacol 1992; 70: 1-7.
23. Putney JW Jr,. Receptor-regulated calcium entry. Pharmacol Ther 1990; 48: 427-434.
24. Putney JW Jr, Bird GS,. The signal for capacitative calcium entry. Cell 1993; 75: 199-201.
25. Vig M, Kinet JP,. Calcium signaling in immune cells. Nat Immunol 2009; 10: 21-27.
26. Stojilkovic SS,. Ca2+-regulated exocytosis and SNARE function. Trends Endocrinol Metab 2005; 16: 81-83.
27. Baram D, Mekori YA, Sagi-Eisenberg R,. Synaptotagmin regulates mast cell functions. Immunol Rev 2001; 179: 25-34. (Pubitemid 32171271)
28. Vause C, Bowen E, Spierings E, Durham P,. Effect of carbon dioxide on calcitonin gene-related peptide secretion from trigeminal neurons. Headache 2007; 47: 1385-1397.
29. Wang YH, Tache Y, Harris AG, Kreutner W, Daly AF, Wei JY,. Desloratadine prevents compound 48/80-induced mast cell degranulation: visualization using a vital fluorescent dye technique. Allergy 2005; 60: 117-124.
30. Durham PL, Russo AF,. Regulation of calcitonin gene-related peptide secretion by a serotonergic antimigraine drug. J Neurosci 1999; 19: 3423-3429.
31. Durham PL, Russo AF,. Stimulation of the calcitonin gene-related peptide enhancer by mitogen-activated protein kinases and repression by an antimigraine drug in trigeminal ganglia neurons. J Neurosci 2003; 23: 807-815.
32. Wei JY, Go VL, Tache Y, Kruger L,. Evidence for uptake of vital dye by activated rat peritoneal mast cells: an in vitro imaging study. Neuroimage 1994; 1: 313-324.
33. Slutsky B, Jarvis D, Bibb P, Feldberg RS, Cochrane DE,. Viability and recovery from degranulation of isolated rat peritoneal mast cells. Exp Cell Res 1987; 168: 63-78.
34. Aridor M, Traub LM, Sagi-Eisenberg R,. Exocytosis in mast cells by basic secretagogues: evidence for direct activation of GTP-binding proteins. J Cell Biol 1990; 111: 909-917.
35. Stenton GR, Nohara O, Dery RE, Vliagoftis H, Gilchrist M, Johri A, et al. Proteinase-activated receptor (PAR)-1 and -2 agonists induce mediator release from mast cells by pathways distinct from PAR-1 and PAR-2. J Pharmacol Exp Ther 2002; 302: 466-474.
36. Chahdi A, Fraundorfer PF, Beaven MA,. Compound 48/80 activates mast cell phospholipase D via heterotrimeric GTP-binding proteins. J Pharmacol Exp Ther 2000; 292: 122-130.
37. Ching TT, Hsu AL, Johnson AJ, Chen CS,. Phosphoinositide 3-kinase facilitates antigen-stimulated Ca(2+) influx in RBL-2H3 mast cells via a phosphatidylinositol 3,4,5-trisphosphate-sensitive Ca(2+) entry mechanism. J Biol Chem 2001; 276: 14814-14820.
38. Mori S, Saino T, Satoh Y,. Effect of low temperatures on compound 48/80-induced intracellular Ca2+ changes and exocytosis of rat peritoneal mast cells. Arch Histol Cytol 2000; 63: 261-270.
39. Bowen EJ, Schmidt TW, Firm CS, Russo AF, Durham PL,. Tumor necrosis factor-alpha stimulation of calcitonin gene-related peptide expression and secretion from rat trigeminal ganglion neurons. J Neurochem 2006; 96: 65-77.
40. Bruno PP, Carpino F, Carpino G, Zicari A,. An overview on immune system and migraine. Eur Rev Med Pharmacol Sci 2007; 11: 245-248.
41. Knaut H, Blader P, Strahle U, Schier AF,. Assembly of trigeminal sensory ganglia by chemokine signaling. Neuron 2005; 47: 653-666.